(Q58168549)

English

Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution (English)

0 references

0 references

chronic pancreatitis

1 reference

based on heuristic

inferred from title

object named as

Sten Madsbad

6

0 references

Jens Juul Holst

object named as

Jens J. Holst

7

0 references

2

object named as

Tina Vilsbøll

0 references

1

object named as

Filip K. Knop

0 references

5

object named as

Aage Vølund

0 references

Patricia M V Højberg

4

object named as

Patricia V. Højberg

0 references

author name string

Steen Larsen

3

0 references

Thure Krarup

8

0 references

publication date

January 2007

0 references

American Journal of Physiology - Endocrinology and Metabolism

0 references

292

0 references

1

0 references

E324-E330

0 references

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Pancreatography in chronic pancreatitis: international definitions

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Pancreatic beta-cell function and glucose metabolism in human segmental pancreas and kidney transplantation.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Nutrient, neural and endocrine control of glucagon-like peptide secretion

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

On the physiology of GIP and GLP-1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Measuring pre-hepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Pancreatic Enzyme Supplementation Therapy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Validation of methods for measurement of insulin secretion in humans in vivo.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Diminished Immunoreactive Gastric Inhibitory Polypeptide Response to a Meal in Newly Diagnosed Type I (Insulin-Dependent) Diabetics*

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Identifiers

10.1152/AJPENDO.00059.2006

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58168549&oldid=1820038270"